Nuclear energy - “Doom or an Asset?” ~Rohan Gupta Oil also referred as “Black Gold” has been the most prominent and conventional energy source known to mankind. We are now at a point where most of the countries are tremendously dependent on it, just like the US economy which has a contribution of 4...Read more
The pandemic exposed supply chain vulnerabilities in the pharmaceuticals industry. A new project aims to transform process development for pharmaceutical raw materials by creating a versatile, modular production framework.
Mike Burgess, P.E., is a Principal Engineer at AVN. He graduated from West Virginia Univ. with a bachelor’s degree in chemical engineering in 1979, is a registered Professional Engineer, and worked at UCC/Dow, where he received the Corporate Fellows award. He holds a number of patents in catalyzed amine process technology. While at UCC/Dow, Burgess provided process fundamentals, reaction engineering, and applied statistics support in R&D and spent several years in ethylene oxide/ethylene glycol (EO/EG) licensing. In 2018 he joined MATRIC (now AVN), where he provides project management...Read more
Devon Burgess is currently a Research Engineer at AVN Corporation. In her role, she oversees project management and provides technical leadership for a variety of contract R&D and small-scale manufacturing projects. Burgess holds a Bachelor of Science in chemical engineering from the Univ. of Kentucky, which she earned in 2014. Before joining AVN Corporation in 2023, Burgess spent nine years at Marathon Petroleum’s Catlettsburg, KY refinery, where she began her career as a refining engineer, initially working in unit engineering before advancing to process design for capital projects....Read more
This meeting will be jointly held with members from the local sections of the American Chemical Society and the American Institute of Chemical Engineers. Three local entrepreneurs will conduct a panel discussion about their experiences in the chemical industry. This technical presentation provides...Read more
Hear from Yuta Lee, Founder & CEO of Accelerated Biosciences, about the inspiration behind his research, what he'll present at the conference, and about new findings in cell therapies and immunotherapy.
